OptiBiotix Health PLC (LSE:OPTI) - Overview

Stock Report

OptiBiotix Health PLC OPTI

Last Price
GBX64.50

Day Change
-0.50|-0.77%

As of 05/12/2016
17:31:20 GMT | GBX
Minimum 15 Minutes Delay.

Last Close65.00p
Day Range64.00 - 64.78
Mkt Cap50.80Mil
52-Wk Range60.00 - 94.00
Yield %0.00
ISINGB00BP0RTP38
Volume118,722
P/E-36.86
P/S1,697.37
P/CF-47.96

Share Price

Total Returns 05/12/2016

 Chg (%)  
More ...
OptiBiotix Health PLC-9.79 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover0.000.000.03
Operating Profit-0.26-0.49-1.42
Net Profit-1.63-0.81-1.28
Reported EPS-347.61-3.03-1.75
Balance Sheet
Current Assets0.302.922.22
Non Current Assets0.002.262.15
Total Assets0.305.184.37
Current Liabilities0.190.080.13
Total Liabilities0.210.530.56
Total Equity0.104.653.82
Cash Flow
Operating Cash Flow-0.37-0.68-0.98
Net Change in Cash0.002.87-0.83
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/12/2015PurchaseMr. David Evans75.0026,66620,000.00
21/12/2015PurchaseMr. Adam Reynolds75.0053,33340,000.00
21/12/2015PurchaseMr. Stephen O'Hara75.0053,33340,000.00
21/12/2015PurchaseMr. Jim Laird75.0013,33310,000.00

Company Profile

OptiBiotix Health PLC is a life sciences company. The Company through its subsidiaries is engaged in the research and development of microbiome modulators.
 

Sector

Biotechnology

Market Position

1069 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(25/08/2016) ceo - "...look forward to an exciting and rewarding rest of 2016"

Next Event 14/04/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)0.0013.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE-67.79206.9680.66
Op Mrgn-5,082.14-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. David Evans
Chief Executive OfficerMr. Stephen O'Hara
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.